<div id="readability-page-1"><div> <div> Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. NEW YORK May 12, 2026 Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)'s sale to Angelini Pharma S.p.A. for $31.50 per share in cash. If you are a Catalyst shareholder, click here to learn more about your rights and options. UniFirst Corporation (NYSE: UNF)'s sale to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share. If you are a UniFirst shareholder, click here to learn more about your rights and options. RE/MAX Holdings, Inc. (NYSE: RMAX)'s sale to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in cash per share. If you are a RE/MAX shareholder, click here to learn more about your rights and options. ACRES Commercial Realty Corp. (NYSE: ACR)'s merger with ACRES Capital Corp. If you are an ACRES Commercial shareholder, click here to learn more about your legal rights and options. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU2UFJfTkVXU19VU1BSX19fX19OWTU3MDY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU2UFJfTkVXU19VU1BSX19fX19OWTU3MDY0"/></div> </div></div>

CPRX

RMAX

Halper Sadeh LLC is investigating Catalyst Pharmaceuticals, UniFirst Corporation, RE/MAX Holdings, and ACRES Commercial Realty for potential violations of federal securities laws. The firm suggests that insiders may benefit financially at the expense of ordinary shareholders. They encourage shareholders to discuss their rights and options at no cost. The investigations relate to proposed sales and mergers involving these companies, with the firm seeking increased consideration and disclosures on behalf of shareholders.

02:56 ETAre CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?